HMGB1 and Duchenne muscular dystrophy: Since HMGB1 protein levels are significantly increased in B10-mdx mice and DMD iSkMs at baseline and decreases with AAV microdystrophin treatment, we propose HMGB1 as a suitable biomarker warranting further investigation.